Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.870
+0.035 (1.91%)
At close: Sep 11, 2026, 4:00 PM EDT
1.840
-0.030 (-1.60%)
After-hours: Sep 11, 2026, 7:57 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $24.94 million as of September 11, 2026. Its market cap has decreased by -91.90% in one year.
Market Cap
24.94M
Enterprise Value
9.32M
1-Year Change
-91.90%
Ranking
Category
Stock Price
$1.87
ChartMarket Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $24.94M, a decrease of -85.39%. That is a compound annual growth rate of -74.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 24.94M | -38.17% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 27.09M |
| BeyondSpring | 25.85M |
| ABVC BioPharma | 25.15M |
| Atossa Therapeutics | 23.95M |
| Cocrystal Pharma | 23.89M |
| NanoViricides | 23.69M |
| Jasper Therapeutics | 23.33M |
| Lantern Pharma | 22.63M |